The first patient was dosed in the Phase 1 ZOLAR 7 trial of TLX300-CDx ( 89 Zr-olaratumab), which aims to validate the use of olaratumab, an antibody exclusively licensed from Eli Lilly and Company ...

A group of advocates for coins and notes is calling on Australians to ensure cash remains viable by making Tuesday a mass ...

Health First’s Viera Hospital again was named one of the best in-state hospitals, and Cape Canaveral Hospital earned its ...